Persistence and adherence in multiple sclerosis patients starting glatiramer acetate treatment: assessment of relationship with care received from multiple disciplines

References

• FreedmanMSDisease-modifying drugs for multiple sclerosis: current and future aspectsExpert Opin Pharmacother20067suppl 1S1S917020427
   PubMed Web of Science ®Google Scholar
• JongenPJLehnickDSandersEFOCUS study groupHealth-related quality of life in relapsing remitting multiple sclerosis patients during treatment with glatiramer acetate: a prospective, observational, international, multi-centre studyHealth Qual Life Outcomes2010813321078142
   PubMed Web of Science ®Google Scholar
• JongenPJSindicCCartonHFunctional composite and quality of Life in Avonex-treated Relapsing multiple sclerosis patients study groupImprovement of health-related quality of life in relapsing remitting multiple sclerosis patients after 2 years of treatment with intramuscular interferon-beta-1aJ Neurol2010257458458919921303
   PubMed Web of Science ®Google Scholar
• TrojanoMPellegriniFPaolicelliDItalian Multiple Sclerosis Database Network (MSDN) GroupReal-life impact of early interferon beta therapy in relapsing multiple sclerosisAnn Neurol200966451352019847899
   PubMed Web of Science ®Google Scholar
• VermeireEHearnshawHVan RoyenPDenekensJPatient adherence to treatment: three decades of research. A comprehensive reviewJ Clin Pharm Ther200126533134211679023
   PubMed Web of Science ®Google Scholar
• World Health OrganizationAdherence to Long-term Therapies: Evidence for ActionGenevaWorld Health Organization2003
   Google Scholar
• UitdehaagBConstantinescuCCornelissePImpact of exposure to interferon beta-1a on outcomes in patients with relapsing-remitting multiple sclerosis: exploratory analyses from the PRISMS long-term follow-up studyTher Adv Neurol Disord20114131421339904
   PubMedGoogle Scholar
• KapposLKuhleJMultanenJFactors influencing long-term outcomes in relapsing-remitting multiple sclerosis: PRISMS-15J Neurol Neurosurg Psychiatry201586111202120726374702
   PubMed Web of Science ®Google Scholar
• SteinbergSCFarisRJChangCFChanATankersleyMAImpact of adherence to interferons in the treatment of multiple sclerosis: a non-experimental, retrospective, cohort studyClin Drug Investig201030289100
   PubMed Web of Science ®Google Scholar
• IvanovaJIBergmanREBirnbaumHGPhillipsALStewartMMeleticheDMImpact of medication adherence to disease-modifying drugs on severe relapse, and direct and indirect costs among employees with multiple sclerosis in the USJ Med Econ201215360160922376190
   PubMedGoogle Scholar
• LafataJECerghetMDobieEMeasuring adherence and persistence to disease-modifying agents among patients with relapsing remitting multiple sclerosisJ Am Pharm Assoc (2003)200848675275719019804
   PubMed Web of Science ®Google Scholar
• MocciaMPalladinoRRussoCHow many injections did you miss last month? A simple question to predict interferon beta-1a adherence in multiple sclerosisExpert Opin Drug Deliv201512121829183526371561
   PubMed Web of Science ®Google Scholar
• JongenPJHengstmanGHuppertsRDrug adherence and multidisciplinary care in patients with multiple sclerosis: protocol of a prospective, web-based, patient-centred, nation-wide, Dutch cohort study in glatiramer acetate treated patients (CAIR study)BMC Neurol2011114021450086
   PubMed Web of Science ®Google Scholar
• Sport MoHWaDutch medical research involving human subjects act (WMO) Available from: http://wetten.overheid.nl/BWBR0009408/2015-12-17Accessed April 29, 2016 Dutch
   Google Scholar
• Summary of product characteristicsCopaxone® 20 mg/ml Solution for Injection, Pre-filled Syringe Available from: http://www.tevauk.com/mediafile/id/15860.pdfAccessed April 29, 2016
   Google Scholar
• GiovannoniGSouthamEWaubantESystematic review of disease-modifying therapies to assess unmet needs in multiple sclerosis: toler-ability and adherenceMult Scler201218793294622249762
   PubMed Web of Science ®Google Scholar
• BergvallNPetrillaAAKarkareSUPersistence with and adherence to fingolimod compared with other disease-modifying therapies for the treatment of multiple sclerosis: a retrospective US claims database analysisJ Med Econ2014171069670725019581
   PubMedGoogle Scholar
• CramerJARoyABurrellAMedication compliance and persistence: terminology and definitionsValue Health2008111444718237359
   PubMed Web of Science ®Google Scholar
• HaasJFirzlaffMTwenty-four-month comparison of immunomodulatory treatments – a retrospective open label study in 308 RRMS patients treated with beta interferons or glatiramer acetate (Copaxone)Eur J Neurol200512642543115885045
   PubMed Web of Science ®Google Scholar
• LangdonDWCognition in multiple sclerosisCurr Opin Neurol201124324424921519256
   PubMed Web of Science ®Google Scholar
• TreadawayKCutterGSalterAFactors that influence adherence with disease-modifying therapy in MSJ Neurol2009256456857619444532
   PubMed Web of Science ®Google Scholar
• BayasAOualletJCKallmannBSMART study groupAdherence to, and effectiveness of, subcutaneous interferon beta-1a administered by RebiSmart(R) in patients with relapsing multiple sclerosis: results of the 1-year, observational SMART studyExpert Opin Drug Deliv20151281239125026098143
   PubMed Web of Science ®Google Scholar
• ReynoldsMWStephenRSeamanCRajagopalanKPersistence and adherence to disease modifying drugs among patients with multiple sclerosisCurr Med Res Opin201026366367420070144
   PubMed Web of Science ®Google Scholar
• CostelloKKennedyPScanzilloJRecognizing nonadherence in patients with multiple sclerosis and maintaining treatment adherence in the long termMedscape J Med200810922519008986
   PubMedGoogle Scholar
• FoebelADHirdesJPHeckmanGACaregiver status affects medication adherence among older home care clients with heart failureAging Clin Exp Res201224671872122732397
   PubMed Web of Science ®Google Scholar
• LemstraMRogersMRThe importance of community consultation and social support in adhering to an obesity reduction program: results from the healthy weights initiativePatient Prefer Adherence201591473148026508843
   PubMed Web of Science ®Google Scholar
• TurnerAPSloanAPKivlahanDRHaselkornJKTelephone counseling and home telehealth monitoring to improve medication adherence: results of a pilot trial among individuals with multiple sclerosisRehabil Psychol201459213614624708232
   PubMed Web of Science ®Google Scholar
• van den BergMJKringosDSMarksLKKlazingaNSThe Dutch Health Care Performance Report: seven years of health care performance assessment in the NetherlandsHealth Res Policy Syst201412124405849
   PubMed Web of Science ®Google Scholar